A subantimicrobial dose of doxycycline effectively controls periodontitis in diabetics, reducing A1c and resulting in a significant decrease in tooth pocket depth.
Read More »Type 1 Diabetes Shrinks the Brain
A loss that might explain why diabetics seem to have higher rates of cognitive impairment throughout life.
Read More »Severity of Diabetic Neuropathy Predicts Charcot Foot Risk
The severity of numbness is directly related to the risk of Charcot foot deformity.
Read More »African-Americans Unaware of Stroke Risks
Nearly 90 percent of the study subjects had a history of high blood pressure, but more than 25 percent did not take medication to control it.
Read More »Diabetic Ulcers Linked to Foot Structure Abnormalities
Bone structure abnormalities and impaired foot and ankle biomechanics in diabetic patients are key risk factors for development of serious ulcers.
Read More »Gene Therapy Seen Hopeful for Patients with Diabetes
New study using a genetic growth factor to repair diabetes-damaged nerves begins.
Read More »ACEIs Standard for Blacks With Renal Insufficiency
Results of a landmark trial of 1,000.
Read More »Patients Taking Pyridorin (Pyridoxamine Dihydrochloride) Conver
The advanced glycation end product (AGE) inhibitor Pyridorin (pyridoxamine dihydrochloride) has potential in treating diabetic nephropathy.
Read More »Lowering Systolic Blood Pressure Reduces Risk of Diabetic Nephr
Reducing systolic blood pressure is critical to slowing the progression of diabetic renal disease, researchers stated at the 35th annual meeting of the American Society of Nephrology (ASN) last week.
Read More »Current Drug Practices Lipid Lowering Agents – Not all that benign
Similar issues arise with the approach toward dyslipidemia. Niacin is effective in reducing TGs and raising HDL but it can increase insulin resistance and deteriorate glycemic control 254, 255 . Nicotinic acid, cholestyramine, fenofibrate and possibly clofibrate increase the concentrations of homocysteine, an independent risk factor for CHD 256, 257 …
Read More »